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Abstract
Rationale: Nasopharyngeal carriage of Streptococcus pneumoniae
is a prerequisite for invasive disease, but the majority of carriage
episodes are asymptomatic and self-resolving. Interactions
determining the development of carriage versus invasive disease are
poorly understood but will inﬂuence the effectiveness of vaccines or
therapeutics that disrupt nasal colonization.
Objectives:We sought to elucidate immunological mechanisms
underlying noninvasive pneumococcal nasopharyngeal carriage.
Methods: Pneumococcal interactions with human nasopharyngeal
and bronchial ﬁbroblasts and epithelial cells were investigated
in vitro. A murine model of nasopharyngeal carriage and an
experimental human pneumococcal challenge model were used to
characterize immune responses in the airways during carriage.
Measurements and Main Results:We describe the previously
unknown immunological basis of noninvasive carriage and highlight
mechanisms whose perturbation may lead to invasive disease. We
identify the induction of active transforming growth factor (TGF)-b1
by S. pneumoniae in human host cells and highlight the key role for
TGF-b1 andT regulatory cells in the establishment andmaintenance
of nasopharyngeal carriage in mice and humans. We identify the
ability of pneumococci to drive TGF-b1 production from
nasopharyngeal cells in vivo and show that an immune tolerance
proﬁle, characterized by elevated TGF-b1 and high nasopharyngeal
T regulatory cell numbers, is crucial for prolonged carriage of
pneumococci. Blockade of TGF-b1 signaling prevents prolonged
carriage and leads to clearance of pneumococci from the nasopharynx.
Conclusions: These data explain the mechanisms by which
S. pneumoniae colonize the human nasopharynx without inducing
damaging host inﬂammation and provide insight into the role of
bacterial and host constituents that allow and maintain carriage.
Keywords: Streptococcus pneumoniae; nasopharynx; immune
tolerance; T-cell regulation; host–pathogen interactions
At a Glance Commentary
Scientiﬁc Knowledge on the Subject: The immunological
mechanisms underpinning nasopharyngeal carriage with
Streptococcus pneumoniae are not fully understood but are crucial
to deciphering why and how carriage may lead to invasive disease.
What This Study Adds to the Field: S. pneumoniae induces
an immunoregulatory response in the naso-oropharynx,
characterized by high levels of transforming growth factor b1
and T regulatory cell inﬁltration, which is conducive to long-
term noninvasive carriage and beneﬁcial to both pathogen and
host. The effects of vaccination strategies on immune
responses in carriage must be reconsidered.
(Received in original form January 23, 2014; accepted in final form April 17, 2014 )
*These authors contributed equally to this work.
This work was supported by the Bill and Melinda Gates Foundation (J.F.G. and S.B.G.) and by the Institute of Infection and Global Health, University of
Liverpool (D.R.N. and A.K.). The EHPC model was funded by the NIHR Biomedical Research Centre and by Bill and Melinda Gates Grand Challenge
Exploration funding.
Author Contributions: D.R.N., W.R.C., S.B.G., and A.K. planned and designed experiments; D.R.N., W.R.C., J.F.G., and L.R. performed experiments; D.R.N.,
W.R.C., S.B.G., and A.K. analyzed the data; W.R.C., J.F.G., F.J.G-G., J.D., S.B.G., and A.K. provided reagents and materials; D.R.N., W.R.C., S.B.G.,
and A.K. contributed to the writing of the manuscript.
Correspondence and requests for reprints should be addressed to Aras Kadioglu, B.Sc., Ph.D., and Daniel R. Neill, M.A., Ph.D., Institute of Infection and Global
Health, University of Liverpool, Ronald Ross Building, 8 West Derby Street, Liverpool L69 7BE, UK. E-mail: a.kadioglu@liv.ac.uk or d.neill@liverpool.ac.uk
This article has an online supplement, which is accessible from this issue’s table of contents at www.atsjournals.org
Am J Respir Crit Care Med Vol 189, Iss 10, pp 1250–1259, May 15, 2014
Copyright © 2014 by the American Thoracic Society
Originally Published in Press as DOI: 10.1164/rccm.201401-0128OC on April 21, 2014
Internet address: www.atsjournals.org
1250 American Journal of Respiratory and Critical Care Medicine Volume 189 Number 10 | May 15 2014
Streptococcus pneumoniae (the
pneumococcus) is an important human
pathogen that accounts for signiﬁcant
morbidity and mortality worldwide,
causing a range of invasive diseases,
including pneumonia, meningitis, and
sepsis. The pneumococcus is also
a commensal of the human nasopharynx,
and colonization of this important
ecological niche is thought to be
a prerequisite for invasive disease (1, 2).
Where carriage rates are highest, risk of
invasive pneumococcal disease is also high
(3, 4). However, the actual incidence of
progression from carriage to invasive
disease (the attack rate) is thought to be less
than 1 in 10,000 (5), suggesting that the
occurrence of invasive disease is the
exception rather than the norm. The
contributory factors that lead to invasive
disease in the minority of such carriage
events are not known, but the host immune
system and its interactions with colonizing
pneumococci is certainly one aspect (3).
Transforming growth factor (TGF)-b1
has a crucial immunosuppressive role in
innate and adaptive immunity (6). TGF-b1
activity limits proinﬂammatory responses
and promotes tissue healing and
remodeling after damage (6), and activation
can occur in response to damage to the
epithelial layer (7). We have demonstrated
the importance of TGF-b1 in invasive
pneumococcal infections, where inhibition
of TGF-b1 markedly increased
susceptibility to invasive pneumonia in
normally disease-resistant mice (8). The
importance of TGF-b1 in the context of
pneumococcal infection of the lung relates
to its ability to drive T regulatory cell
differentiation and expansion, and the
correlation of high TGF-b1 levels and T
regulatory cell numbers with reduced lung
apoptosis suggests that immune regulation
plays a key role in preventing bacterial
dissemination by limiting inﬂammatory
damage to the lung epithelial barrier (8).
Correlative evidence suggests T
regulatory cells also play a role in
nasopharyngeal colonization: children with
pneumococcus positive nasopharyngeal
swabs contained higher proportions of T
regulatory cells in adenoidal tissue than
children with pneumococcus negative
cultures (9). We sought to elucidate the
host–pathogen interactions underpinning
asymptomatic nasopharyngeal carriage.
Identifying the immune phenotype in the
carrier state will aid our understanding of
how this equilibrium is disturbed in
invasive disease.
Some of the results of these studies have
been previously reported in the form of an
abstract (10).
Methods
Ethics Statement
The UK Home Ofﬁce and University of
Liverpool ethics committee approved the
study. Animal experiments were performed
at the University of Liverpool. Ethical
approval for human experimental
pneumococcal challenge was obtained from
the National Health Service Research Ethics
Committee (08/H1001/52 and 11/NW/
0592).
Mice
Female MF1 mice (9–14 wk of age)
(Charles River, Margate, UK) were
acclimatized for 1 week before use.
Bacteria
Mouse-virulent serotype 2 Streptococcus
pneumoniae strain D39 (NCTC 7466) or its
isogenic pneumolysin (Ply)-deﬁcient
mutant PLN-A were used throughout the
experiment. Infectious doses were prepared
as described previously (11). Samples
from experimental human pneumococcal
challenge were taken from patients
challenged with serotype 6B pneumococci
(12).
Pneumolysin
Recombinant Ply was expressed in
Escherichia coli and puriﬁed as previously
described (13). Additional details are
provided in the online supplement.
Infection of Mice
Animals were infected intranasally with 13
105 colony-forming units (CFU) (low-dose)
S. pneumoniae D39 or PLN-A or with
1 3 107 CFU (high-dose) D39 in 10 ml PBS
as previously described (14). Mice were
culled by cervical dislocation, and
nasopharynx and lungs were prepared for
assessment of bacterial CFU or leukocytes.
A viable count of bacteria in murine tissue
was determined at prechosen intervals as
previously described (14). Colonization for
48 hours or more was considered a carriage
event. Additional details are provided in
the online supplement.
P17 Treatment of Mice
Animals were infected intranasally with 13
105 CFU S. pneumoniae D39 and then
immediately administered 500 mg of the
peptide TGF-b1 inhibitor P17 (15) or PBS
by intraperitoneal injection. Further doses
of P17 or PBS were given at 1, 3, and 4 days
after infection. This treatment regime was
chosen to inhibit infection-induced TGF-
b1 production without appreciably altering
homeostatic TGF-b1 levels in the
nasopharynx.
Experimental Human Pneumococcal
Challenge Model and Nasal Wash
Healthy adults with no respiratory disease
and no natural carriage were recruited.
Pneumococci were instilled in 100 ml saline
into each naris. Nasal wash was performed
at 48 hours after inoculation (12, 16). The
presence of carriage was assessed by serial
dilution of nasal wash onto blood agar.
Additional details are provided in the
online supplement.
Flow Cytometry
Tissue cell suspensions were stained for
surface markers or transcription factors as
previously described (8). Samples were
analyzed using a FACScalibur ﬂow
cytometer (Becton Dickinson, Oxford, UK)
running CellQuest acquisition and analyzed
using FlowJo (version 8.8.3; Tree Star,
Ashland, OR). Additional details are
provided in the online supplement.
Cell Culture
The nasopharyngeal cell line Detroit 562
(NE), immortalized human bronchial
epithelial cells (J.W. Shay, University of
Texas, Dallas, TX) (17), primary human
bronchial ﬁbroblasts (C.A. Feghali-
Bostwick, University of Pittsburgh School
of Medicine, Pittsburgh, PA) (18), and
human nasopharyngeal ﬁbroblasts (Institut
d’Investigacions Biome`diques August Pi I
Sunyer and Centro de Investigaciones
Biome´dicas en Red de Enfermedades
Respiratorias, Barcelona, Spain) (19) were
cultured as described in the online
supplement. Cells were grown to conﬂuence
before addition of Ply or live or heat-killed
D39. After 24 hours, culture supernatants
were collected and stored at 2808C.
MTT Assay
Cell toxicity was assessed by the 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium
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bromide (MTT) assay. Before the assay, culture
supernatants were centrifuged at 13,000 3 g
for 2 minutes, and the supernatant was passed
through a 0.2-mm ﬁlter. Subsequently, 20 ml
MTT (5 mg/ml) (Sigma Aldrich, Gillingham,
UK) in culture media was added to cells and
incubated for 1 hour. Medium was removed,
and 100 ml of dimethyl sulfoxide (Sigma
Aldrich) was added for 30 minutes.
Absorbance was read at 550 nm. Values are
expressed as % MTT absorbance of medium
control.
Identiﬁcation of Cytokines
Active TGF-b1 within supernatants was
determined using luciferase-reporting
transformed mink lung epithelial cells (D.B.
Rifkin, Langone Medical Center and School
of Medicine, New York University, New
York) as previously described (20).
Additional details are provided in the
online supplement.
Statistics
Data were analyzed in GraphPad Prism
using a two-tailed unpaired Student’s t test
or one- or two-way ANOVA with post-
tests. Results with P values , 0.05 were
considered signiﬁcant. Data represent
mean 6 SEM unless otherwise indicated.
Results
Elevated In Vivo Levels of TGF-b1 and
T Regulatory Cell Numbers in the
Nasopharynx Are Associated with
Prolonged Pneumococcal Carriage
in Murine and Human Models of
Respiratory Challenge
Low-density colonization of pneumococci
(z500 pneumococci per mg of
nasopharyngeal tissue or 5,000 per ml
recovered nasal homogenate) induces
prolonged carriage in mice (Figure 1A),
characterized by a lack of inﬂammation and
no progression to invasive disease (14).
In contrast, high-density pneumococcal
colonization (z10,000 pneumococci per
mg of nasopharyngeal tissue or 100,000 per
ml homogenate) induces transient carriage
that is cleared within 2 weeks of infection
(Figure 1A). Even with high-density
colonization, pneumococci do not establish
infection in the lungs, and disease signs
do not materialize (data not shown).
Similarly, intranasal infection with an
isogenic Ply-deﬁcient mutant of S.
pneumoniae D39 (PLN-A), at the same low
dose that establishes prolonged carriage
when wild-type (WT) D39 are used, fails to
induce carriage but leads to transient
colonization (14) (Figure 1A). We
hypothesized that failure to carry high
densities of WT pneumococci or a lower
density of its Ply-deﬁcient mutant might be
the result of an altered balance of pro- and
anti-inﬂammatory cytokine production in
the upper airways as compared with low-
density WT carriage, which promotes
conditions that favor stable carriage. To
explore this, levels of active TGF-b1,
a major immunoregulatory cytokine, were
measured in nasopharyngeal tissue samples
taken over the ﬁrst 2 weeks of low-density
colonization with WT or PLN-A or high-
density colonization with WT (Figure 1B).
All infections induced rapid elevation of
TGF-b1 in the nasopharynx within
24 hours (Figure 1B). However, TGF-b1
returned to preinfection levels in high-
density WT (by Day 3) or PLN-A (by
Day 7) colonization, despite the continuing
presence of bacteria in the nasopharynx,
but elevated TGF-b1 levels were maintained
in low-density WT colonization, only
declining in the second week of carriage
(Figure 1B). Thus, sustained elevation of
TGF-b1 levels in the nasopharynx is
associated with prolonged pneumococcal
carriage, and maintenance of TGF-b1
depends upon colonization density
and Ply. IL-10, another major
immunomodulatory cytokine, was
elevated in the nasopharynx of low-density
WT, high-density WT, and PLN-A
colonized mice between Days 1 and 3 after
infection, but no signiﬁcant differences
were observed between groups.
We have previously shown that
TGF-b1–induced T regulatory cell
activity has a critical role in the outcome
of pneumococcal pneumonia (8). To
examine whether nasopharyngeal
TGF-b1 drives T regulatory cell responses
during carriage, we assessed
CD41Foxp31 T regulatory cell numbers
in murine nasopharyngeal homogenates
after low- or high-density colonization
with WT or PLN-A pneumococci.
Elevated T regulatory cell numbers were
observed at 3, 7, and 14 days after low-
density WT colonization but not after
PLN-A or high-density WT colonization
(Figure 1D).
A major function of TGF-b1 and T
regulatory cells is to limit the production of
proinﬂammatory cytokines. Levels of IFN-g
were elevated in nasopharyngeal
homogenates of high-density colonized
WT, but not in low-density WT or PLN-A
colonized mice, at Days 1 and 3 after
infection (Figure 1E). Furthermore, the
ratio of IFN-g to TGF-b1 demonstrated the
proinﬂammatory state of the nasopharynx
in high-density colonized mice (Figure 1F).
The involvement of TGF-b1 signaling
pathways in the establishment of carriage
is not restricted to mice. Analysis of active
TGF-b1 levels in nasal washes from
volunteers recruited to a unique
experimental human pneumococcal
carriage model where healthy adults are
intranasally challenged with live
pneumococci (12, 16) revealed that mean
Figure 1. Prolonged nasopharyngeal carriage is associated with a regulatory cytokine and cellular environment characterized by high transforming growth
factor (TGF)-b1 and T regulatory cell numbers. (A–C) Mice were challenged with 13 105 CFU D39 (low dose, open circles) or PLN-A (closed diamonds) or
with 1 3 107 CFU D39 (high dose, open squares) in 10 ml PBS. (A) Colony-forming units (CFU) per mg nasopharynx. (B) Active TGF-b1 levels determined
by the luciferase-reporting transformed mink lung epithelial cell assay. (C) IL-10 levels determined by ELISA from nasopharyngeal homogenates. (D)
T regulatory cells (Foxp31CD41) per mg nasopharynx as determined by flow cytometry. p.i. = postinfection. Data in A through D are representative of three
independent experiments with more than five mice per group per time point. For low-dose D39, asterisks represent significant difference according
to two-way ANOVA from high-dose D39 (*P , 0.05; **P , 0.01; ***P , 0.001), and number symbols represent significant difference from PLN-A group
(#P , 0.05; ##P , 0.01; ###P , 0.001). (E and F) IFN-g (E) and IFN-g:TGF-b1 (F) determined by ELISA from nasopharyngeal homogenates. Data are
from a single experiment with five mice per group. Asterisks represent significant difference according to two-way ANOVA from low-dose D39 (*P , 0.05;
**P , 0.01; ***P , 0.001). (G and H) Active TGF-b1 (G) and IL-10 (H) in human nasal wash taken 48 hours after experimental pneumococcal
challenge. Each point represents a single individual in which 6B pneumococcal carriage was detected (carriage 1) or not detected (carriage 2) when
nasal wash was plated on blood agar. Data are from a single experiment. *P , 0.05; **P , 0.01 (Student’s t test).
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TGF-b1 levels are higher in volunteers in
whom carriage successfully establishes after
pneumococcal challenge than in those who
fail to develop carriage (Figure 1G).
Furthermore, assessment of IL-10, another
marker of immunomodulation and
tolerance (21), revealed elevated levels in
carriage-positive individuals but not in
those who fail to carry (Figure 1H).
Carriage density in volunteers tested in
the study averaged 10,000 pneumococci
per ml recovered nasal wash, which is
comparable to that seen when long-term
carriage is successfully established in mice
(5,000 per ml nasopharyngeal homogenate)
(Figure 1A).
These data demonstrate the increased
immunoregulatory activity in the
nasopharynx of mice and humans during
prolonged low-density episodes of
carriage.
Carriage Is Associated with Reduced
Polymorphonuclear Leukocyte
Inﬁltration and an Accumulation of
Alternatively Activated Macrophages
in the Nasopharynx
To assess the impact of increased
immunoregulatory activity in the
nasopharynx during carriage, neutrophil
and macrophage numbers were assessed.
High- or low-density colonization withWT
or low-density colonization with PLN-A
led to inﬁltration of neutrophils into the
nasopharynx by 24 hours (Figure 2A).
However, neutrophil numbers were
reduced by Day 3 after infection, and this
decline was signiﬁcantly more rapid in
low-density colonization with WT than in
high-density WT or with PLN-A
(Figure 2A).
Macrophage numbers increased in the
nasopharynx during all infections and were
signiﬁcantly elevated at Days 3 and 7 after
infection as compared with prechallenge
levels (Figure 2B). Although macrophage
numbers in nasopharynx at Day 7 after
infection were comparable in all infection
groups, a signiﬁcantly higher proportion of
macrophages from the low-density WT
colonization group (69%) expressed
mannose receptor than from the high-
density colonization with WT (29%) or
PLN-A (26%) (Figure 2C). This result
suggests that alternative activation of
macrophages might occur in the
nasopharynx of mice during long-term
carriage, and this is supported by the
observation of high levels of major
histocompatibility complex class II
expression on the mannose
receptor–expressing macrophages from
low-density WT colonized mice, as
compared with mannose receptor–negative
Figure 2. Carriage is associated with decreased polymorphonuclear leukocyte (PMN) infiltration of the nasopharynx and alternative activation of
macrophages. Mice were challenged with 1 3 105 colony-forming units (CFU) D39 (low dose, open circles) or PLN-A (closed diamonds) or with 1 3 107
CFU D39 (high dose, open squares) in 10 ml PBS. Neutrophil (PMN) (A) and macrophage (B) numbers per mg nasopharynx, as determined by flow
cytometry. Neutrophils are defined as SSclowCD451Gr-1hiCD11bhiF4/80int/low; macrophages are defined as SSchiCD451Gr-12F4/80hi. p.i. = post
infection. CD206 (mannose receptor) (C) and major histocompatibility complex class (MHCII) expression on macrophages (D) at Day 7 after infection. Data
in A through D are representative of three independent experiments with more than five mice per group per time point. For low-dose D39 in A and C,
asterisks represent significant difference according to two-way ANOVA from high-dose D39 (*P , 0.05; **P , 0.01), and number symbols represent
significant difference from PLN-A (##P , 0.01).
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macrophages or macrophages from high-
density infections (Figure 2D).
Together, these data demonstrate that
local immune responses are altered in the
nasopharynx during long-term
pneumococcal carriage. High levels of TGF-
b1 and T regulatory cells, reduced
neutrophil inﬁltration, and alternative
activation of macrophages characterize this
response, whereas lower TGF-b1 and T
regulatory cell levels and prolonged
neutrophil inﬁltration aligned with classical
macrophage activation favor clearance of
infection.
Human Nasopharyngeal Epithelial
Cells and Fibroblasts Secrete Active
TGF-b1 in Response to Live
S. pneumoniae and Ply
To elucidate the mechanism by which
pneumococcal colonization of the
nasopharynx induced immunoregulatory
responses, human nasopharyngeal
ﬁbroblasts or epithelial cells were treated
with pneumococci, resulting in signiﬁcant
induction of active TGF-b1 (Figures 3A and
3B). TGF-b1 production was completely
abrogated in assays performed with heat-
killed D39 or PLN-A (Figures 3A–3D).
TGF-b1 production drops off substantially
at the highest D39 CFU numbers (2.5 3
106) tested in ﬁbroblasts and to a lesser
extent in epithelial cells (Figures 3A–3D),
suggesting differential host responses to
differing bacterial densities. This drop
cannot be explained by increased cell death
alone in the case of ﬁbroblasts because they
retain 100% viability even at 3 3 106 D39
CFU (Figure 3E). By contrast, the slight
drop in TGF-b1 at high CFU numbers in
epithelial cells (Figures 3B and 3D) may be
due to the signiﬁcant cell death observed at
these bacterial concentrations (Figure 3F).
Furthermore, consistent with the
observation that Ply is required for
induction of active TGF-b1 production,
puriﬁed Ply was sufﬁcient to induce TGF-
b1 production from epithelial cells and
ﬁbroblasts (Figures 3G and 3H).
We have conducted preliminary
investigations into the mechanistic detail of
TGF-b1 induction in epithelial cells and
ﬁbroblasts of the upper and lower airways
(see Figures E1 and E2 in the online
supplement). Our ﬁndings implicate the
NLRP3 inﬂammasome (Figure E1) and
suggest the responses to pneumococci
differ in the upper and lower airways
(Figure E2).
TGF-b1 Blockade Prevents Prolonged
Carriage of Pneumococci in
the Nasopharynx
To determine whether immunomodulatory
responses are essential for prolonged
pneumococcal carriage, we administered the
P17 peptide inhibitor of TGF-b1 (8).
Administration of P17 to mice 1 hour
before intranasal administration of
a colonizing low dose of pneumococci, and
Figure 3. Pneumococci and pneumolysin induce active transforming growth factor (TGF)-b1
production in nasopharyngeal fibroblasts and epithelial cells. Active TGF-b1 determined from
nasopharyngeal fibroblast (A, C, E, G) and nasopharyngeal epithelial cell (B, D, F, H) supernatants by
luciferase-reporting transformed mink lung epithelial cell assay after stimulation with D39, heat-
inactivated D39, pneumolysin (Ply)-deficient S. pneumoniae (PLN-A), or recombinant endotoxin free Ply.
Survival of D39 and PLN-A stimulated nasopharyngeal fibroblasts (E) and nasopharyngeal epithelial
cells (F ) determined by MTT assay. Medium alone was used as control. Open circles = D39; closed
squares = heat-inactivated D39 (A and B) or PLN-A (C–F). Asterisks in parentheses denote significant
active TGF-b1 induction induced by D39 over heat-inactivated D39 (A and B) or PLN-A (C and D)
((*)P , 0.05; (**)P , 0.01). Asterisks denote significant active TGF-b1 induction induced by D39 over
untreated cells (*P , 0.05; **P , 0.01). Analysis is from two-way (A–D) or one-way (G) ANOVA.
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Figure 4. Impaired transforming growth factor (TGF)-b1 signaling leads to a failure to confine pneumococci to the nasopharynx and to early clearance of
carriage. Mice were challenged with 1 3 105 colony-forming units (CFU) D39 and then given 500 mg P17 peptide (open squares) or PBS (closed circles)
ORIGINAL ARTICLE
1256 American Journal of Respiratory and Critical Care Medicine Volume 189 Number 10 | May 15 2014
subsequently at 1, 3, and 4 days after
infection, profoundly reduced
pneumococcal carriage in the nasopharynx
(Figure 4A). Although initial colonization
density was unaffected in P17-treated mice,
by 4 days after infection mice had
signiﬁcantly lower bacterial numbers in the
nasopharynx as compared with PBS-treated
controls (1.65 log10 mean CFU per mg
tissue vs. 3.38 log10 CFU per mg), and by
7 days after infection three out of four P17-
treated mice had cleared carriage, whereas
all control mice still had high densities
of colonized bacteria in the nasopharynx.
Before clearing of the infection, P17-treated
mice experienced a transient translocation
of pneumococci from nasopharynx to lungs
between Days 1 and 4 after infection
(Figure 4B). This bacterial translocation
was completely absent in control animals.
Blockade of TGF-b1 led to a failure to
induce T regulatory cell responses in the
nasopharynx (Figure 4C), although IL-10
production was unaffected (Figure 4D).
TGF-b1 blockade was also associated with
an exacerbated inﬂammatory response
characterized by increased neutrophil inﬂux
of the nasopharynx (Figure 4E).
Collectively, these data highlight the
key role of TGF-b1 and T regulatory cells
in limiting proinﬂammatory responses in
the nasopharynx and in allowing the
persistence of pneumococcal carriage. It
is likely that in different situations
dysregulation of TGF-b1 signaling would
lead to either pathogen clearance or
pathogen dissemination to deeper tissues.
Discussion
S. pneumoniae is a pathogen of signiﬁcant
clinical importance, and elucidating its
interactions with host immunity is
crucial to our understanding of its
pathogenesis. Here we identify the major
immunoregulatory cytokine TGF-b1 as
the key determinant of the duration of
pneumococcal colonization of the upper
airways. Low pneumococcal carriage
density induces immunoregulatory
responses characterized by sustained
elevation of nasopharyngeal TGF-b1 and T
regulatory cell numbers and alternative
activation of macrophages. Consequently,
pneumococci are maintained at low density
in the nasopharynx for prolonged periods
without becoming invasive. By contrast,
high-density colonization induces strong
inﬂammatory responses that supersede the
TGF-b1–driven pathway and thus clear
bacteria from the nasopharynx. The use of
the P17 peptide (8, 15, 22) to directly
inhibit TGF-b1 demonstrates the critical
role of regulatory responses in mediating
long-term pneumococcal carriage because
mice fail to raise T regulatory cell responses
in the nasopharynx and rapidly clear
bacteria from the upper airways in the
absence of TGF-b1 signaling.
The suppression of inﬂammatory
responses by S. pneumoniae–induced TGF-
b1 and T regulatory cells may be important
to preserve the balance of ﬂora and lessen
tissue damage, but it is clear that regulatory
responses are also essential for the
prolonged carriage of pneumococci in the
upper airways; thus, targeting TGF-b1
signaling may be a means to eliminate
carriage, a prerequisite for invasive disease.
TGF-b1 inhibition did not prevent
establishment of pneumococcal
colonization in the nasopharynx, but
bacteria were gradually cleared over the
ﬁrst week of infection. This correlated with
a failure to induce T regulatory responses in
the nasopharynx in response to bacterial
colonization; hence, in line with our in vitro
human airway epithelial cell culture data,
we favor a model whereby pneumococci
induce airway epithelial cell TGF-b1
production, which drives induced T
regulatory cell generation in the
nasopharynx. These T regulatory cells limit
proinﬂammatory responses, preventing
tissue damage but also allowing persistence
of carriage. In support of this model,
neutrophil inﬂux into the nasopharynx was
greatly enhanced in P17-treated mice,
although we cannot rule out direct or T
regulatory cell–independent effects of TGF-
b1 on neutrophil function, as has been
reported previously (23, 24). The
observation that nasopharyngeal IL-10
levels were unaffected in P17-treated mice
suggests that T regulatory cells are not the
exclusive source of IL-10 and that IL-10
alone is not sufﬁcient to maintain carriage.
However, the clear correlation between
establishment of carriage and elevated nasal
wash IL-10 in experimental human
pneumococcal carriage suggests that IL-10
may play some role in the colonization
process.
A consequence of the reduced T
regulatory cell activity in P17-treated mice
was a transient colonization of the lung by
S. pneumoniae. We postulate that the
normal role of T regulatory cells in the
nasopharynx is to prevent this bacterial
spread by limiting inﬂammatory tissue
damage. A prolonged but contained
infection is better for the host than an
uncontrolled but shorter one.
In contrast to low-density colonization,
high densities of pneumococcal colonization
(a “high-risk” dose) induce only transient
TGF-b1 production in the nasopharynx,
with signiﬁcantly reduced T regulatory cell
inﬁltration and, instead, an inﬂammatory
phenotype characterized by neutrophil
inﬁltration, classical activation of
macrophages, and IFN-g production
dominates. Consequently, bacteria are
cleared from the nasopharynx before
invasive disease can develop. We postulate
that deregulation of the balance between
immune tolerance and inﬂammatory
reactivity leads to invasive disease. We have
shown that Ply is a key driver of TGF-b1
and regulatory responses, and it may follow
that cases of human invasive disease with
pneumococci that have Ply with reduced or
no hemolytic activity (such as some
serotype-1 strains) (25) result from the
failure to balance immune responses after
infection
Our observations in the murine
carriage model are supported by data
obtained using a unique experimental
human pneumococcal carriage model
(12, 16). We show that individuals who
successfully carry pneumococci in their
nasopharynx by 48 hours after challenge
have signiﬁcantly higher levels of TGF-b1
and IL-10 in nasal wash samples than those
Figure 4. (Continued). at 0, 1, 3, and 4 days after infection. (A) CFU per mg nasopharynx. (B) CFU per mg lung. (C) T regulatory cells (defined as
Foxp31CD41) per mg nasopharynx as determined by flow cytometry. (D) IL-10 levels in nasopharyngeal homogenates determined by ELISA. (E)
Neutrophils (polymorphonuclear leukocytes [PMN] defined as SSclowCD451Gr-1hiCD11bhiF4/80int/low) per mg nasopharynx as determined by
flow cytometry. Data are from a single experiment with 16 mice per treatment. Asterisks represent significant difference according to two-way ANOVA
(*P , 0.05; **P , 0.01; ***P , 0.001).
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who clear the challenge dose. To the
best of our knowledge, this is the ﬁrst
demonstration in mouse and human
models of nasopharyngeal colonization that
regulatory cytokines play a key role in
sustaining pneumococcal colonization.
Carriage density in colonized human
volunteers was comparable to what we
observed when long-term carriage is
successfully established in mice.
We have demonstrated that
S. pneumoniae and Ply directly stimulate
production of TGF-b1 from human airway
epithelial cells and ﬁbroblasts. We show
that host pattern recognition receptors
play an essential role in this interaction
and that the dependency upon ion efﬂux,
cathepsin B, and lysosomal degradation
implicates the NLRP3 inﬂammasome in
the signaling process. Furthermore, we
have demonstrated that this occurs
through a mechanism dependent upon
potassium efﬂux, as has been
demonstrated for cytokine production
induced by the pore-forming toxins of
Staphylococcus aureus (26) and Aeromonas
hydrophilia (27).
Alternative activation of macrophages
induces up-regulation of a characteristic set
of surface markers, including the mannose
receptor and major histocompatibility
complex class II (28), and appears to be
a characteristic of prolonged pneumococcal
carriage in our model. Production of TGF-
b1 by alternatively activated macrophages
has been documented (29), and the cells
have been implicated in tissue repair and
remodeling (30) and in protection of
the host from damaging inﬂammation
during pathology (31, 32). In the context
of pneumococcal nasopharyngeal
colonization, they may limit inﬂammation
to prevent tissue damage and thus promote
prolonged carriage.
Our results highlight the delicate
balance between the requirements of the
host to maintain epithelial barrier integrity
and prevent inﬂammatory tissue damage
with the need to combat potentially
dangerous pathogen colonization. This
equilibrium needs to be considered in the
design of anti-pneumococcal therapeutics
and vaccines that alter the density of
pneumococcal carriage and hence affect
upper airways immune responses. We
hypothesize that the prolonged but
contained and controlled carriage mediated
by T regulatory cells allows the host time to
mount protective memory immune
responses against the pneumococcus that
may protect against invasive disease. We
have previously demonstrated the potential
for natural carriage to boost vaccine
responses (33). Furthermore, elucidation
of factors conducive to carriage or
clearance may open up avenues for
treatments tailored to patients, where
levels of immunomodulatory cytokine in
nasal wash might be used as a predictor
of future responses to infection or
vaccination. n
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